Results 1 to 10 of about 40,312 (250)
Is There a Potential of Misuse for Venlafaxine and Bupropion? [PDF]
Frontiers in Pharmacology, 2018 Objective: Traditionally, studies on the non-medical use of pharmaceutical products have focused on controlled substances; e.g., opiates/opioids; and benzodiazepines.
Fabrizio Schifano, Stefania Chiappini
doaj +5 more sources
Rapid bupropion-induced hepatotoxicity: a case report and review of the literature [PDF]
Journal of Medical Case Reports, 2018 Background Bupropion is an antidepressant that is also used as a non-nicotine method to aid in smoking cessation. Bupropion-induced hepatotoxicity is quoted to affect between 0.1% and 1% of treated patients with either a hepatocellular and/or cholestatic
Sulakchanan Anandabaskaran, Vincent Ho
doaj +2 more sources
Drugs of Today, 2006 Bupropion was initially developed and licensed for the treatment of major depressive disorder in the United States in 1989. It was licensed as a pharmacotherapy for smoking cessation in the United States in 1997 and in the United Kingdom in 2000, and for the prevention of seasonal major depressive episodes in patients with seasonal affective disorder ...
europepmc +4 more sources
Effects of Administration of Perinatal Bupropion on the Population Spike Amplitude in Neonatal Rat Hippocampal Slice [PDF]
Iranian Journal of Basic Medical Sciences, 2010 Objective(s)Bupropion is an atypical antidepressant that is widely used in smoke cessation under FDA approval. The study of synaptic effects of bupropion can help to finding out its mechanism(s) for stopping nicotine dependence. In this study the effects
Soomaayeh Heysieat-talab +3 more
doaj +2 more sources
Neuropsychiatric Disease and Treatment, 2009 David C Henshall1, Nick Dürmüller2, H Steve White3, Robert Williams4, Paul Moser2, Mark Dunleavy1, Peter H Silverstone51Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland; 2Porsolt and ...
David C Henshall +3 more
doaj +3 more sources
Bupropion Reduces Some of the Symptoms of Marihuana Withdrawal in Chronic Marihuana Users: A Pilot Study [PDF]
Substance Abuse: Research and Treatment, 2012 Bupropion's (Zyban ® SR) effectiveness to treat symptoms experienced in marihuana withdrawal was tested in a double-blind, placebo-controlled study with chronic, heavy marihuana users.
David M. Penetar +4 more
doaj +4 more sources
Basic and Clinical Neuroscience, 2014 Introduction: The most common interpretation for the mechanisms of antidepression is the increase of the brain monoamine levels such as dopamine (DA).
Sanaz Amirabadi +5 more
doaj +3 more sources
Successful use of ECMO and lipid emulsion for massive bupropion overdose: a case report
Toxicology Communications, 2021 Introduction Bupropion overdose can produce seizures, arrhythmias, and shock. The toxicokinetics of massive bupropion ingestions are not well characterized.Case report A 22-year-old female ingested an estimated 40.5 g (644 mg/kg) of extended release ...
Michael E. O’Brien +5 more
doaj +1 more source
Adsorption of Bupropion on C60 Nanocage: Thermodynamic and Electronic Properties [PDF]
Nanochemistry Research, 2022 Bupropion is a drug primarily used for treating major depressive disorder and helping smokers quit smoking. Bupropion is a fairly effective antidepressant, but it leads to restlessness and palpitations at relatively high doses. In addition, it is used as
Zhila NazarAli +3 more
doaj +1 more source